Atrial fibrillation

Patient with history of atrial fibrillation:  1 trials  - ANTIPAF

olmesartan vs placebo

No demonstrated result

Diabetes type 2

All type of patients:  2 trials  - ROADMAP - ORIENT

olmesartan vs placebo

No demonstrated result

suggested Cardiovascular death by 312% (not demonstrated)

See more clinical conditions

Patients with or without hypertension:  2 trials  - ROADMAP - ORIENT

olmesartan vs placebo

No demonstrated result

suggested Cardiovascular death by 312% (not demonstrated)

Diabetic kidney disease

All type of patients:  1 trials  - ORIENT

olmesartan vs placebo

No demonstrated result

Miscellaneous

All type of patients:  2 trials  - ROADMAP - ORIENT

olmesartan vs placebo

No demonstrated result

suggested Cardiovascular death by 312% (not demonstrated)